Vnitr Lek 2000, 46(9):565-568

[Pharmacotherapy of hyperlipoproteinemia].

V Soska
Oddĕlení klinické biochemie FN U sv. Anny, Brno.

Hyperlipoproteinaemia is one of the main risk factors of ischaemic heart disease. The centre of gravity of its pharmacotherapy with hypolipidaemic agents is secondary prevention of ischaemic heart disease. In patients in primary prevention of ischaemic heart disease pharmacotherapy is indicated only in case of high risk, if non-pharmacological treatment does not lead to achievement of target values of blood lipids. Available hypolipidaemic drugs on our market include statins, fibrates and resins. A suitable preparation should be selected with regard to the type of hyperlipidaemia. A constant part of treatment with hypolipidaemic drugs must be also non-pharmacological treatment which in the majority should precede pharmacotherapy.

Keywords: Coronary Disease, etiology, ; Humans; Hyperlipoproteinemias, complications, ; Hypolipidemic Agents, therapeutic use, ; Risk Factors

Published: September 1, 2000  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Soska V. [Pharmacotherapy of hyperlipoproteinemia]. Vnitr Lek. 2000;46(9):565-568.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)

    • Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.